Fenbendazole has been used as an anthelmintic drug for dogs to treat parasitic worm infestations since the 1970s. However, multiple peer-reviewed reports and research on the capacity of fenbendazole to aggressively cure tumors in people have been published, as have case reports.
The facts are addressed in the following points, which indicate a legitimate differentiation between fenbendazole and other chemotherapy therapies.
There are several scientific studies that support and demonstrate the efficacy of fenbendazole in the treatment of a few major human malignancies.
For example, studies have shown that utilizing fenbendazole alone may successfully assist to reverse tumors in people with severe B-cell lymphoma, renal cell carcinoma, metastatic cancer, and bladder cancer.
According to studies, the adverse effects of taking fenbendazole are minor, making it suitable for human consumption.
It has a relatively low manufacturing cost and it is readily obtained from local pharmacies and retailers.
Nonetheless, according to a research from our article ‘How does fenbendazole function,’ fenbendazole and other plant alkaloids from the Taxol group that are often used for chemotherapy have a comparable impact on tumors. Furthermore, because of its unique action and outstanding safety profile, fenbendazole’s toxicity is substantially lower than that of other cancer-treatment drugs.
Following certain research and clinical trials, unique characteristics and patterns have indicated that the presence of parasites, bacteria, and viruses is the primary cause of most malignancies.
In reality, this is frequently the case in the majority of cancer cases, particularly when the cancer-causing material is in an environment that promotes its development without impediment, such as genes, impaired immune systems, and so on.
This is why, when contemplating cancer treatment choices for both comprehensive and traditional approaches, employing pharmaceuticals that may combat these parasites, worms, and bacteria is typically suggested.
Humans and fenbendazole
Fenbendazole is not the same as mebendazole, which is intended for human usage. Fenbendazole is a drug that was developed to treat parasites and worms in birds, fish, and other animals such as roundworm, hookworm, tapeworm, and whipworm.
Fenbendazole is widely available and marketed under the brand names SafeGuard and Panacur. Several years ago, during one of our studies, we found this medication. We were interested in it again when a guy testified to the medication’s success in the treatment of small cell lung cancer.
Following that, this man created a website as well as a Facebook page to document his experience as well as the experiences of others who have had a similar recovery using this medication for various cancer types such as stage four pancreatic cancer, melanoma, prostate cancer, nonsmall cell lung cancer, colorectal cancer, and many more.
Benzimidazole family medications have been proved to be useful against cancer, and these current findings corroborate and substantiate this notion. As a result, we feel that employing medications such as fenbendazole and mebendazole for cancer therapy is one of the most effective solutions.
Indeed, several investigations have shown mebendazole to be less effective than fenbendazole. For example, studies have shown that fenbendazole is superior than mebendazole in treating Cryptococcus neoformans, a common fungus that is thought to be the cause of Cryptococcus meningitis in the majority of people.
Aside from most study studies indicating that fenbendazole is beneficial in combating tumors in cancer patients, a report indicated that fenbendazole fights cancer by acting as a destabilizing agent to microtubules and alters various cellular pathways, ultimately leading to cancer death.
Combining this idea with our earlier research indicated that fenbendazole helps to prevent the creation and spread of malignant cells and tumors, making it a potential treatment option that can inhibit many biological processes that induce malignant cell death.
According to the report’s authors, fenbendazole attacks cancer cells by not only interrupting the microtubule system and the development of the malignant cells, but also by preventing the transfer of sugar, which causes their death in the long run. Fenbendazole inhibits the expression of GLUT 4 (glucose transporter isoform 4).
Glucose is often absorbed into the plasma membrane through intracellular vesicles, resulting in activation of the absorbed glucose. The interruption of this absorption during the linear migration along the microtubule caused by fenbendazole inhibits the mobility of GLUT4, resulting in restricted uptake of insulin-stimulated glucose.
Although fenbendazole’s impact on tubulin is comparable to that of colchicine, it cannot be compared to that of vinca alkaloids, which distinguishes it from other chemotherapeutic approaches. However, fenbendazole, like other benzimidazole compounds, may boost the effectiveness of several cancer treatments such as surgery, berberine, sodium dichloroacetate (DCA), radiation, and so on.
Combining this result with a previous scientific paper implies that fenbendazole may restart the genome p53. The genome p53 normally works as a tumor suppressor, yet certain tumors are resistant to its suppression.
Furthermore, according to a Nature Paper, combining fenbendazole with DCA for chemotherapy is particularly efficient against cancer.
Is fenbendazole a good drug for humans?
Despite the fact that the original function of fenbendazole for sale is to expel worms and parasites in animals, the European Medicines Agency stated in a report that humans consuming fenbendazole appear to have little or no side effects (A single dose of about 2000mg/individual or 500mg/individual for 10 days consecutively).
Although there is yet to be any data on the long-term effects of the medicine. This may be attributed to the drug’s efficacy, since it can help remove symptoms within two weeks.
Despite this, many people take fenbendazole to prevent cancer recurrence or as a conventional treatment for chemotherapy. Fenbendazole has been demonstrated to have no known negative effects.
Helen Baumeister did her degree in psychology at the University of Hertfordshire. She is interested in mental health, wellness, and lifestyle.